Marc I. Lorber

7.3k total citations · 1 hit paper
119 papers, 5.0k citations indexed

About

Marc I. Lorber is a scholar working on Transplantation, Surgery and Molecular Biology. According to data from OpenAlex, Marc I. Lorber has authored 119 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Transplantation, 52 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Marc I. Lorber's work include Renal Transplantation Outcomes and Treatments (53 papers), Organ Transplantation Techniques and Outcomes (27 papers) and Transplantation: Methods and Outcomes (18 papers). Marc I. Lorber is often cited by papers focused on Renal Transplantation Outcomes and Treatments (53 papers), Organ Transplantation Techniques and Outcomes (27 papers) and Transplantation: Methods and Outcomes (18 papers). Marc I. Lorber collaborates with scholars based in United States, Switzerland and Canada. Marc I. Lorber's co-authors include Jordan S. Pober, George Tellides, Barry D. Kahan, Jeffrey S. Schechner, Stuart M. Flechner, Charles T. Van Buren, Margaret J. Bia, Amy L. Friedman, Alfred L.M. Bothwell and Nancy C. Kirkiles-Smith and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Marc I. Lorber

119 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genetically Modified Porcine-to-Human Cardiac Xenotransplantation

2022 365 citations Bartley P. Griffith, Corbin E. Goerlich et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Marc I. Lorber

Since Specialization

Citations

This map shows the geographic impact of Marc I. Lorber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc I. Lorber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc I. Lorber more than expected).

Fields of papers citing papers by Marc I. Lorber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc I. Lorber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc I. Lorber. The network helps show where Marc I. Lorber may publish in the future.

Co-authorship network of co-authors of Marc I. Lorber

This figure shows the co-authorship network connecting the top 25 collaborators of Marc I. Lorber. A scholar is included among the top collaborators of Marc I. Lorber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc I. Lorber. Marc I. Lorber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetically Modified Porcine-to-Human Cardiac Xenotransplantation breakdown → 2022 ·New England Journal of Medicine ·Bartley P. Griffith, Corbin E. Goerlich, Avneesh K. Singh, Martine Rothblatt, Christine L. Lau, Aakash Shah, Marc I. Lorber, Alison Grazioli, Kapil Saharia, Susie N. Hong, Susan Joseph, David Ayares, Muhammad M. Mohiuddin	365
2	FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one‐yr multicenter study 2009 ·Clinical Transplantation ·Hélio Tedesco‐Silva, Marc I. Lorber, C. Foster, Hans W. Sollinger, Robert Mendez, (unknown), Ron Shapiro, P. R. Rajagopalan, (unknown), (unknown), B D Kahan	17
3	Development of a Humanized Mouse Model to Study the Role of Macrophages in Allograft Injury 2009 ·Transplantation ·Nancy C. Kirkiles-Smith, Martha J. Harding, Benjamin R. Shepherd, (unknown), Tai Yi, Yinong Wang, Jennifer M. McNiff, Edward L. Snyder, Marc I. Lorber, George Tellides, Jordan S. Pober	28
4	A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation 2007 ·American Journal of Transplantation ·Flavio Vincenti, R. Méndez, Mark D. Pescovitz, P. R. Rajagopalan, Alan Wilkinson, Khalid M.H. Butt, David A. Laskow, Douglas P. Slakey, Marc I. Lorber, Jay Garg, Marvin R. Garovoy	116
5	Immunosuppressive Therapy Protocols in Kidney Transplantation in Adults 2006 ·Bosnian Journal of Basic Medical Sciences ·(unknown), Marc I. Lorber, Richard N. Formica, (unknown), (unknown), (unknown), (unknown)	1
6	Human Allograft Arterial Injury Is Ameliorated by Sirolimus and Cyclosporine and Correlates with Suppression of Interferon-?? 2006 ·Transplantation ·Tai Yi, (unknown), Yinong Wang, Kian Peng Koh, (unknown), George Tellides, Jordan S. Pober, Marc I. Lorber	20
7	A Multicenter Pilot Study of Early (4-Day) Steroid Cessation in Renal Transplant Recipients Under Simulect, Tacrolimus and Sirolimus 2005 ·American Journal of Transplantation ·E. Steve Woodle, Flavio Vincenti, Marc I. Lorber, H. Albin Gritsch, Donald E. Hricik, Kenneth Washburn, Arthur J. Matas, M Gallichio, John F. Neylan	76
8	T cell–mediated vascular dysfunction of human allografts results from IFN-γ dysregulation of NO synthase 2004 ·Journal of Clinical Investigation ·Kian Peng Koh, Yinong Wang, Tai Yi, Stephen L. Shiao, Marc I. Lorber, William C. Sessa, George Tellides, Jordan S. Pober	83
9	The evolving experience using everolimus in clinical transplantation 2004 ·Transplantation Proceedings ·Richard N. Formica, (unknown), Amy L. Friedman, Margaret J. Bia, Fadi G. Lakkis, Janie Smith, Marc I. Lorber	41
10	Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation 2003 ·Transplantation Proceedings ·Richard N. Formica, (unknown), Amy L. Friedman, Margaret J. Bia, Fadi G. Lakkis, Janie Smith, Marc I. Lorber	22
11	Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation 2002 ·Transplantation ·Sandy Feng, Joseph F. Buell, Wida S. Cherikh, Mario C. Deng, Douglas W. Hanto, H. Myron Kauffman, Alan B. Leichtman, Marc I. Lorber, (unknown), Maureen McBride, Robert A. Metzger, Frederick S. Nolte, (unknown), David Roth, Norah A. Terrault, Mitchell L. Henry	54
12	RAD IN DE NOVO RENAL TRANSPLANTATION: COMPARISON OF THREE DOSES ON THE INCIDENCE AND SEVERITY OF ACUTE REJECTION 1 2001 ·Transplantation ·(unknown), Bruce Kaplan, Marc I. Lorber, M. Winkler, (unknown), R. Boger	87
13	Preliminary results of a liver allocation plan using a continuous medical severity score that de-emphasizes waiting time 2001 ·Liver Transplantation ·Richard B. Freeman, Richard J. Rohrer, Eliezer Katz, (unknown), Roger L. Jenkins, A. Benedict Cosimi, Francis L. Delmonico, Amy L. Friedman, Marc I. Lorber, Kevin O’Connor, James W. Bradley	53
14	Human TNF Can Induce Nonspecific Inflammatory and Human Immune-Mediated Microvascular Injury of Pig Skin Xenografts in Immunodeficient Mouse Hosts 2000 ·The Journal of Immunology ·Nancy C. Kirkiles-Smith, Denis A. Tereb, Richard W. Kim, Jennifer M. McNiff, Jeffrey S. Schechner, Marc I. Lorber, Jordan S. Pober, George Tellides	29
15	POSTTRANSPLANT BONE DISEASE: EVIDENCE FOR A HIGH BONE RESORPTION STATE 2000 ·Transplantation ·(unknown), John J. Wysolmerski, Christine Simpson, Mary Ann Mitnick, Caren Gundberg, Alan S. Kliger, Marc I. Lorber, David Silver, (unknown), (unknown), Karl Insogna, Dinna N. Cruz, Margaret J. Bia	80
16	Body size mismatch between donor and recipient and the development of chronic rejection in renal transplantation 1997 ·Transplantation Proceedings ·(unknown), Luiz Augusto Auersvald, Elizabeth B. Claus, Margaret J. Bia, Amy L. Friedman, Marc I. Lorber, Giacomo Basadonna	14
17	Must living renal donors be hospitalized overnight prior to surgery? 1996 ·Clinical Transplantation ·Amy L. Friedman, (unknown), (unknown), Giacomo Basadonna, Richard A. Wiklund, Alan S. Kliger, Margaret J. Bia, Marc I. Lorber	2
18	HEPATIC RETRANSPLANTATION IN NEW ENGLAND—A REGIONAL EXPERIENCE AND SURVIVAL MODEL 1993 ·Transplantation ·John A. Powelson, A. Benedict Cosimi, (unknown), Richard J. Rohrer, Richard B. Freeman, Joseph P. Vacanti, (unknown), Marc I. Lorber, William H. Marks, James W. Bradley, Roger L. Jenkins	57
19	THE IMMUNOCHEMICAL DISTRIBUTION OF CYCLOPHILIN IN NORMAL MAMMALIAN TISSUES 1991 ·Transplantation ·William H. Marks, Matthew W. Harding, Robert E. Handschumacher, CHRISTINE MARKS, Marc I. Lorber	38
20	A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone. 1983 ·The Journal of Experimental Medicine ·D W Lancki, Marc I. Lorber, Michael R. Loken, F W Fitch	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact